1169 related articles for article (PubMed ID: 12090979)
1. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
3. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
4. Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.
Pedrazzoli P; Noris P; Perotti C; Schiavo R; Ponchio L; Belletti S; Da Prada GA; Balduini CL; Salvaneschi L; Robustelli Della Cuna G; Siena S
Br J Haematol; 2000 Mar; 108(3):653-9. PubMed ID: 10759725
[TBL] [Abstract][Full Text] [Related]
5. Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO.
Vadhan-Raj S; Currie LM; Bueso-Ramos C; Livesey SA; Connor J
Br J Haematol; 1999 Feb; 104(2):403-11. PubMed ID: 10050726
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery.
Yokomuro M; Ebine K; Shiroma K; Tamura S; Kumabe S; Ohtuki M; Suzuki H; Uchida S
Cryobiology; 1999 May; 38(3):236-42. PubMed ID: 10328913
[TBL] [Abstract][Full Text] [Related]
8. Review of in vivo studies of dimethyl sulfoxide cryopreserved platelets.
Slichter SJ; Jones M; Ransom J; Gettinger I; Jones MK; Christoffel T; Pellham E; Bailey SL; Corson J; Bolgiano D
Transfus Med Rev; 2014 Oct; 28(4):212-25. PubMed ID: 25439164
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B; Alberio L; Rochat S; Stenner F; Manz MG; Buser A; Schanz U; Stussi G
Transfusion; 2016 Oct; 56(10):2426-2437. PubMed ID: 27339466
[TBL] [Abstract][Full Text] [Related]
11. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
15. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
[TBL] [Abstract][Full Text] [Related]
18. Bleeding prophylaxis in autologous bone marrow transplantation for solid tumors. Comparison of cryopreserved autologous and fresh allogeneic single-donor platelets.
Mulder PO; Maas A; de Vries EG; Orie JL; Sleijfer DT; Smit Sibinga CT; Willemse PH; Mulder NH
Haemostasis; 1989; 19(2):120-4. PubMed ID: 2659444
[TBL] [Abstract][Full Text] [Related]
19. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
20. The use of PEG-rhuMGDF in platelet apheresis.
Kuter DJ
Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]